The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Bupropion as an add‐on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence
Abstract
OBJECTIVES: The treatment of bipolar disorder type I (BD-I) with a comorbid cocaine dependence disorder (CDD) is a challenge in current psychiatric practice. Drugs with proven efficacy in manic/mixed episodes, such as atypical antipsychotics and mood stabilizers, sometimes do not prevent depressive relapses; on the other hand, the use of antidepressants during acute depressive episodes may increase the risk of a manic switch. The aim of the present study was to investigate the short-term efficacy of bupropion augmentation in acutely depressed BD-I patients with co-occurring CDD. METHODS: Twelve depressed BD-I patients, with a comorbid CDD, treated with valproate 1000 to 1500 mg/d and aripiprazole 10 mg/d, were randomly assigned to receive bupropion 150 mg/d as an open-label add-on therapy (n = 5) or to continue their previous treatment (n = 7). RESULTS: After 4 weeks of observation, patients receiving add-on therapy with bupropion have improved in terms of Hamilton Depression Rating Scale scores and Drug Abuse Screening Test scores, with respect to those of the comparison group, whereas no significant increase of Young Mania Rating Scale scores over time was observed. CONCLUSIONS: Our preliminary findings suggest that combining bupropion with mood stabilizers and atypical antipsychotics may be a good therapeutic option in short-term treatment of depressed BD-I patients with comorbid CDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bupropion has anecdotal reports favouring efficacy in cocaine use disorders (level 4).713”
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Skinner, H. A. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90005-3 · Cited by 3,134 · cited 1×
“The secondary end point was to evaluate the improvement on symptoms of drug abuse, as measured by the Drug Abuse Screening Test (DAST).(34) Symptoms of manic/hypomanic switches were also measured by means of the Young Mania Rating Scale (YMRS).”
MethodYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Huang, B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1001 · Cited by 479 · cited 1×
“In large epidemiological studies on BD-I patients, lifetime prevalence rates of alcohol or other SUDs were of 60% and 40%, respectively.(3,4) The relations between BD and SUD are complex, and patients may be divided into different subgroups: 1) those using alcohol or drugs as a self-medication for depressive and manic…”
BackgroundLeverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.232 · Cited by 419
Substance abuse in bipolar disorder
Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.30403.x · Cited by 385 · cited 1×
“Awide percentage of bipolar disorder type I (BD-I) patients are affected by comorbid substance use disorders (SUDs),(1) with alcohol, Cannabis, and cocaine as most involved substances.(2) In large epidemiological studies on BD-I patients, lifetime prevalence rates of alcohol or other SUDs were of 60% and 40%, respecti…”
BackgroundMania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256 · cited 1×
“Treatmentemergent mania has been especially associated with antidepressants (ADs), although recent data suggest that this risk has been probably overestimated.(6,7) On the other hand, efficacious treatments for manic/mixed episodes, such as secondgeneration antipsychotics (SGAs) and mood stabilizers (MSs), sometimes d…”
Background
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Fountoulakis, K. Ν., Yatham, L. N., Grunze, H., Vieta, E., Young, A. H., Blier, P., Kasper, S. F., & Moeller, H. J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw100 · Cited by 126
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Solmi, M., Monaco, F., Veronese, N., De Berardis, D., & de Bartolomeis, A. (2018) · Bipolar Disorders · doi:10.1111/bdi.12612 · Cited by 93
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
Poon, S. H., Sim, K., & Baldessarini, R. J. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630171954 · Cited by 73
Functional magnetic resonance imaging of internet addiction in young adults
Sepede, G., Tavino, M., Santacroce, R., Fiori, F., Salerno, R. M., & Giannantonio, M. D. (2016) · World Journal of Radiology · doi:10.4329/wjr.v8.i2.210 · Cited by 62
Self-citation
Metadata
- Authors
- Sepede, G., Di lorio, G., Lupi, M., Sarchione, F., Acciavatti, T., Fiori, F., Santacroce, R., Martinotti, G., Gambi, F., & Di Giannantonio, M.
- Affiliations
- University of Chieti-Pescara (IT)
- Corresponding author
- Sepede, Gianna
- Lupi, Matteo
- Sarchione, Fabiola
- Acciavatti, Tiziano
- Fiori, Federica
- Santacroce, Rita
- Martinotti, Giovanni
- Gambi, Francesco
- Venue
- Clinical Neuropharmacology
- Published
- 2014-01
- Volume
- 37
- Issue
- 1
- Pages
- 17-21
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2144025991
- Cited by
- 16
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 1
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- bupropion, bipolar I disorder, cocaine dependence, comorbidities, adjunctive therapy, antidepressant augmentation, depressive episodes, manic switch, valproic acid, aripiprazole, mood stabilizers, atypical antipsychotics
- MeSH terms
- Aripiprazole, Adolescent, Adult, Analysis of Variance, Bipolar Disorder, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Piperazines, Psychiatric Status Rating Scales, Antipsychotic Agents, Valproic Acid, Quinolones, Bupropion, Antidepressive Agents, Second-Generation, Cocaine-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bupropion as an add‐on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence. https://app.cochat.ai/papers/10.1097/wnf.0000000000000011
- The paper
- Sepede, G., Di lorio, G., Lupi, M., Sarchione, F., Acciavatti, T., Fiori, F., Santacroce, R., Martinotti, G., Gambi, F., & Di Giannantonio, M. (2014). Bupropion as an add‐on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.